Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
76,682.45
(
-0.01%
)
News Focus
News Focus
Post# of 257624
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 90636

Tuesday, 02/16/2010 5:30:28 AM

Tuesday, February 16, 2010 5:30:28 AM

Post# of 257624
Has Copaxone topped out in the US market?

4Q09 US Copaxone sales of $509M were +33% year-over-year, but they were down 6% vs the $540M booked in 3Q09. Unless the quarter-over-quarter drop was the result of inventory destocking, it could signify that Copaxone demand in the US market has topped out.

Comments?


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today